Tenax Therapeutics Inc. – Filings and Transcripts

NASDAQ: TENX
Share price (5/5/26): $12.49
Market cap (5/5/26): $322 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement

Shelf registration

Registration of securities for employees

Prospectus supplement

Ownership Filter

Invus Global Management, LLC

Ikarian Capital, LLC

Giordano Christopher Thomas

Logos Global Management LP

News Filter

Appoints Thomas R. Staab, II as Chief Financial Officer

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Announces Result of Prespecifed Blinded Sample Size Assessment

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC